vs

Side-by-side financial comparison of Medirom Healthcare Technologies Inc. (MRM) and PARKE BANCORP, INC. (PKBK). Click either name above to swap in a different company.

PARKE BANCORP, INC. is the larger business by last-quarter revenue ($22.7M vs $21.1M, roughly 1.1× Medirom Healthcare Technologies Inc.). PARKE BANCORP, INC. runs the higher net margin — 48.8% vs -21.3%, a 70.1% gap on every dollar of revenue. PARKE BANCORP, INC. produced more free cash flow last quarter ($39.0M vs $-2.4K).

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

Parke Bancorp, Inc. is a U.S. regional bank holding company operating Parke Bank. It offers commercial and retail banking services including deposit products, mortgage loans, small business financing and personal lending, primarily serving customers across New Jersey and the Philadelphia metropolitan area.

MRM vs PKBK — Head-to-Head

Bigger by revenue
PKBK
PKBK
1.1× larger
PKBK
$22.7M
$21.1M
MRM
Higher net margin
PKBK
PKBK
70.1% more per $
PKBK
48.8%
-21.3%
MRM
More free cash flow
PKBK
PKBK
$39.0M more FCF
PKBK
$39.0M
$-2.4K
MRM

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
MRM
MRM
PKBK
PKBK
Revenue
$21.1M
$22.7M
Net Profit
$-4.5M
$11.1M
Gross Margin
10.8%
Operating Margin
-28.5%
64.2%
Net Margin
-21.3%
48.8%
Revenue YoY
35.7%
Net Profit YoY
49.8%
EPS (diluted)
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRM
MRM
PKBK
PKBK
Q4 25
$22.7M
Q3 25
$21.0M
Q2 25
$21.1M
$18.7M
Q1 25
$17.4M
Q4 24
$16.8M
Q3 24
$15.6M
Q2 24
$15.5M
Q1 24
$15.1M
Net Profit
MRM
MRM
PKBK
PKBK
Q4 25
$11.1M
Q3 25
$10.6M
Q2 25
$-4.5M
$8.3M
Q1 25
$7.8M
Q4 24
$7.4M
Q3 24
$7.5M
Q2 24
$6.5M
Q1 24
$6.2M
Gross Margin
MRM
MRM
PKBK
PKBK
Q4 25
Q3 25
Q2 25
10.8%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
MRM
MRM
PKBK
PKBK
Q4 25
64.2%
Q3 25
64.2%
Q2 25
-28.5%
59.0%
Q1 25
59.1%
Q4 24
58.0%
Q3 24
60.2%
Q2 24
56.7%
Q1 24
55.4%
Net Margin
MRM
MRM
PKBK
PKBK
Q4 25
48.8%
Q3 25
50.6%
Q2 25
-21.3%
44.3%
Q1 25
44.6%
Q4 24
44.2%
Q3 24
48.1%
Q2 24
41.6%
Q1 24
40.7%
EPS (diluted)
MRM
MRM
PKBK
PKBK
Q4 25
$0.93
Q3 25
$0.89
Q2 25
$0.69
Q1 25
$0.65
Q4 24
$0.61
Q3 24
$0.62
Q2 24
$0.53
Q1 24
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRM
MRM
PKBK
PKBK
Cash + ST InvestmentsLiquidity on hand
$252.3K
Total DebtLower is stronger
$8.8M
Stockholders' EquityBook value
$1.6M
$324.5M
Total Assets
$52.0M
$2.2B
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRM
MRM
PKBK
PKBK
Q4 25
Q3 25
Q2 25
$252.3K
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
MRM
MRM
PKBK
PKBK
Q4 25
Q3 25
Q2 25
$8.8M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MRM
MRM
PKBK
PKBK
Q4 25
$324.5M
Q3 25
$314.8M
Q2 25
$1.6M
$312.2M
Q1 25
$305.9M
Q4 24
$300.1M
Q3 24
$296.5M
Q2 24
$292.8M
Q1 24
$288.4M
Total Assets
MRM
MRM
PKBK
PKBK
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$52.0M
$2.2B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.0B
Q1 24
$2.0B
Debt / Equity
MRM
MRM
PKBK
PKBK
Q4 25
Q3 25
Q2 25
5.55×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRM
MRM
PKBK
PKBK
Operating Cash FlowLast quarter
$-2.3K
$39.6M
Free Cash FlowOCF − Capex
$-2.4K
$39.0M
FCF MarginFCF / Revenue
-0.0%
171.3%
Capex IntensityCapex / Revenue
0.0%
2.6%
Cash ConversionOCF / Net Profit
3.57×
TTM Free Cash FlowTrailing 4 quarters
$63.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRM
MRM
PKBK
PKBK
Q4 25
$39.6M
Q3 25
$11.4M
Q2 25
$-2.3K
$6.8M
Q1 25
$7.0M
Q4 24
$35.2M
Q3 24
$9.4M
Q2 24
$8.9M
Q1 24
$8.3M
Free Cash Flow
MRM
MRM
PKBK
PKBK
Q4 25
$39.0M
Q3 25
$11.2M
Q2 25
$-2.4K
$6.7M
Q1 25
$6.6M
Q4 24
$35.0M
Q3 24
$9.4M
Q2 24
$8.9M
Q1 24
$8.3M
FCF Margin
MRM
MRM
PKBK
PKBK
Q4 25
171.3%
Q3 25
53.5%
Q2 25
-0.0%
35.8%
Q1 25
38.0%
Q4 24
209.1%
Q3 24
60.0%
Q2 24
57.1%
Q1 24
55.1%
Capex Intensity
MRM
MRM
PKBK
PKBK
Q4 25
2.6%
Q3 25
0.5%
Q2 25
0.0%
0.3%
Q1 25
2.2%
Q4 24
0.7%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.1%
Cash Conversion
MRM
MRM
PKBK
PKBK
Q4 25
3.57×
Q3 25
1.07×
Q2 25
0.82×
Q1 25
0.90×
Q4 24
4.75×
Q3 24
1.25×
Q2 24
1.38×
Q1 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

PKBK
PKBK

Segment breakdown not available.

Related Comparisons